Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Local Anesthetics: Common Agents and Their Applications01:23

Local Anesthetics: Common Agents and Their Applications

460
Local anesthetics (LAs) are commonly used for various applications in medical and dental procedures. Some of the common agents used are cocaine, lidocaine, and bupivacaine.
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
460
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

459
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
459
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

536
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
536
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

359
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
359
Local Anesthetics: Clinical Application as Surface, Infiltration, and Conduction Block Anesthesia01:30

Local Anesthetics: Clinical Application as Surface, Infiltration, and Conduction Block Anesthesia

1.1K
Depending on the target organ, local anesthetics (LAs) can be administered via various routes. In surface anesthesia, LAs are applied directly to the surface of the skin or mucous membranes. It is widely used for topical skin numbing before venipuncture or minor surgical procedures. Commonly used surface local anesthetics are lidocaine or benzocaine sprays or creams. Surface anesthesia occurs within 5 minutes and lasts for about 60 minutes. One of the main disadvantages of topical anesthesia is...
1.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Culmerciclib: First Approval.

Drugs·2026
Same author

Correction: Plozasiran: First Approval.

Drugs·2026
Same author

Durvalumab: A Review in Limited-Stage Small Cell Lung Cancer.

Targeted oncology·2026
Same author

Plozasiran: First Approval.

Drugs·2026
Same author

Puzolcabtagene Autoleucel: Pediatric First Approval.

Paediatric drugs·2026
Same author

Donidalorsen: First Approval.

Drugs·2025

相关实验视频

Updated: Jul 13, 2025

Novel Photoacoustic Microscopy and Optical Coherence Tomography Dual-modality Chorioretinal Imaging in Living Rabbit Eyes
09:20

Novel Photoacoustic Microscopy and Optical Coherence Tomography Dual-modality Chorioretinal Imaging in Living Rabbit Eyes

Published on: February 8, 2018

10.9K

洛蒂拉纳眼科溶液0.25%:首次获得批准

Yahiya Y Syed1

  • 1Springer Nature, Mairangi Bay, Private Bag 65901, Auckland, 0754, New Zealand. dru@adis.com.

Drugs
|October 16, 2023
PubMed
概括

洛蒂拉纳眼科溶液0.25% (XDEMVYTM) 现在已在美国批准用于治疗Demodex白炎. 这种胺酸的化通道抑制剂向虫诱导的眼睛疾病.

科学领域:

  • 眼科医生 眼科 眼科
  • 寄生虫学的寄生虫学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 德莫德克斯白炎和德莫德克斯诱导的梅博米安炎是由德莫德克斯虫感染引起的常见眼睛疾病.
  • 目前对Demodex盖膜感染的治疗选择有限,这凸显了对新型治疗剂的需求.
  • 洛蒂拉纳眼科溶液0.25% (XDEMVYTM) 是一种针对这些疾病的根本原因的新型治疗方法.

研究的目的:

  • 总结一下lotilaner0.25%眼科溶液的开发里程碑,从而获得美国的批准.
  • 要突出lotilaner作为选择性虫GABA-Cl抑制剂的作用机制.
  • 提供有关眼部疾病正在进行的临床开发的概述.

主要方法:

  • 对洛提拉纳眼科溶液的临床前和临床开发数据的审查0.25%.
  • 美国监管提交和批准过程的分析.
  • 目前正在进行的第二期和第三期临床试验的总结.

主要成果:

  • 洛蒂拉纳0.25%眼科溶液于2023年7月24日首次获得美国批准,用于Demodex白炎.
  • 该药物被证明是作为对虫的选择性胺酸化通道 (GABA-Cl) 抑制剂的有效性.
  • 目前正在进行的试验正在评估其在中国对Demodex诱导的梅炎和Demodex白炎的潜力.

更多相关视频

A Reversible Silicon Oil-Induced Ocular Hypertension Model in Mice
09:03

A Reversible Silicon Oil-Induced Ocular Hypertension Model in Mice

Published on: November 15, 2019

9.9K
Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
06:19

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology

Published on: May 31, 2024

859

相关实验视频

Last Updated: Jul 13, 2025

Novel Photoacoustic Microscopy and Optical Coherence Tomography Dual-modality Chorioretinal Imaging in Living Rabbit Eyes
09:20

Novel Photoacoustic Microscopy and Optical Coherence Tomography Dual-modality Chorioretinal Imaging in Living Rabbit Eyes

Published on: February 8, 2018

10.9K
A Reversible Silicon Oil-Induced Ocular Hypertension Model in Mice
09:03

A Reversible Silicon Oil-Induced Ocular Hypertension Model in Mice

Published on: November 15, 2019

9.9K
Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
06:19

Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology

Published on: May 31, 2024

859

结论:

  • 洛蒂拉纳眼科溶液0.25%标志着在治疗Demodex白炎方面取得了重大进展.
  • 批准意味着对患有Demodex盖膜感染的患者提供了新的治疗选择.
  • 预计进一步开发将扩大与之相关的眼睛表面疾病的治疗选择.